SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: sim19/2/2009 3:02:52 PM
   of 10280
 
UPDATE 1-Dainippon Sumitomo to bid for Sepracor - Nikkei
Wed Sep 2, 2009 1:53pm EDT

Sept 3 (Reuters) - Japan's Dainippon Sumitomo Pharma Co Ltd (4506.T: Quote, Profile, Research, Stock Buzz) plans to launch a bid to acquire Sepracor Inc (SEPR.O: Quote, Profile, Research, Stock Buzz) for about 250 billion yen ($2.70 billion), the Nikkei business daily said.

Shares of Marlborough, Massachusetts-based Sepracor jumped as much as 30 percent to $23.37 Wednesday on Nasdaq.

The move is intended to boost Dainippon Sumitomo Pharma's lineup of central nervous system and other drugs, the paper said without citing sources.

Sepracor officials were not immediately available for comment.

Funding for the purchase will come from sources including cash on hand and loans, the Nikkei said.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext